# Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

> **NCT00291408** · PHASE4 · WITHDRAWN · sponsor: **Imperial College London**

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)
- Age Matched Healthy Volunteers (Non-smokers)

## Interventions

- **PROCEDURE:** Skin Prick Test
- **PROCEDURE:** Impulse Oscillometry
- **PROCEDURE:** Exhaled Nitric Oxide
- **PROCEDURE:** Spirometry
- **PROCEDURE:** Reversibility
- **PROCEDURE:** Exhaled Breath Condensate
- **PROCEDURE:** Sputum Induction

## Key facts

- **NCT ID:** NCT00291408
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-04
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Researchers left the institute
- **Last updated:** 2019-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291408, "Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00291408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*